Cirugía endovascular como tratamiento de la Esclerosis Múltiple

Nogales-Gaete, Jorge; Eloiza, Claudio; Cepeda-Zumaeta, Sergio; Aracena, Rodrigo; Agurto, Paula

doi:10.4067/s0034-98872011000500020

Cited by 3 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, it is more frequent and severe in progressive MS than in RRMS, which suggests that cognitive deficits tend to aggravate due to the exhaustion of nervous system reserve over time. 167 Some studies from European countries 168 – 170 and Latin America 171 reported the prevalence of CI was between 34% and 65%. Generally, the older patients are likely to have worse cognitive performances than young patients, while CI is mostly directly related to MS itself and not similar to the decline in CI with general aging.…”

Section: Clinical Featuresmentioning

confidence: 99%

Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

Wang,

Liu,

Zou

et al. 2023

Ther Adv Neurol Disord

View full text Add to dashboard Cite

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system characterized by inflammation, demyelination, and neurodegeneration. It mainly affects young adults, imposing a heavy burden on families and society. The epidemiology, clinical features, and management of MS are distinct among different countries. Although MS is a rare disease in China, there are 1.4 billion people in China, so the total number of MS patients is not small. Because of the lack of specific diagnostic biomarkers for MS, there is a high misdiagnosis rate in China, as in other regions. Due to different genetic backgrounds, the clinical manifestations of MS in Chinese are different from those in the West. Herein, this review aims to summarize the disease comprehensively, including clinical profile and the status of disease-modifying therapies in China based on published population-based observation and cohort studies, and also to compare with data from other countries and regions, thus providing help to develop diagnostic guideline and the novel therapeutic drugs. Meanwhile, we also discuss the problems and challenges we face, specifically for the diagnosis and treatment of MS in the middle- and low-income countries.

show abstract

Section: Clinical Featuresmentioning

confidence: 99%

Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

Wang,

Liu,

Zou

et al. 2023

Ther Adv Neurol Disord

View full text Add to dashboard Cite

show abstract

“…[ 2 ] Relapsing-remitting MS (RRMS) is characterized by relapses or flare-ups that may have different durations and intensity of the symptoms and often result in transition to secondary-progressive MS (SPMS). [ 3 4 5 ]…”

Section: Introductionmentioning

confidence: 99%

Assessing muscle fatigue in multiple sclerosis using the sample entropy of electromyographic signals: A proof of concept

Viloria-Barragán,

Gomez-Hernández,

Olaya-Mira

et al. 2023

J Med Signals Sens

View full text Add to dashboard Cite

“…La EM afecta alrededor de 2,3 millones de personas en el mundo (Browne et al, 2014), con una prevalencia en Chile de aproximadamente 11,7 por 100.000 habitantes, (Ministerio de Salud [MINSAL], 2010). En nuestro país la media de edad de confirmación diagnóstica se ubica entre los 27 y los 30 años, con una prevalencia mayor entre las mujeres: 67% (Nogales- Gaete et al, 2014).…”

Section: Introductionunclassified

Estudio exploratorio para la validación de la Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) en la población con Esclerosis Múltiple Remitente Recurrente del Hospital San Juan de Dios en Santiago de Chile

Matus

Carrasco

Guajardo

et al. 2022

Rev. Chil. Fonoaudiol.

View full text Add to dashboard Cite

La evaluación cognitiva en personas con esclerosis múltiple (EM), es un área fundamental a tener en cuenta en el proceso de intervención, debido a la alta prevalencia de deterioro cognitivo el cual es considerado como discapacitante y que repercute en la calidad de vida de la persona que lo padece y en su red más próxima. En la actualidad se ha recomendado la evaluación cognitiva por medio de la BICAMS (del inglés Brief International Cognitive Assessment for MS), que es una batería específica para evaluar a personas con EM, pero que no cuenta con su validación en nuestro país. Es por esto que el presente estudio busca determinar los factores que se deben considerar para su futura validación. La muestra estuvo compuesta por 38 personas con EMRR y como resultado se obtuvo que sí influyen en el rendimiento cognitivo los factores de edad y género, no así escolaridad, meses de evolución de la enfermedad y nivel de discapacidad. Dentro de las pruebas cognitivas el BVMT-R es el que más demostró, y de forma significativa, relación con las variables de edad y género. Se recomienda aumentar el tamaño muestral y aplicarlo en otras regiones del país para contar con una muestra representativa de la población chilena.

show abstract

Cirugía endovascular como tratamiento de la Esclerosis Múltiple

Cited by 3 publications

References 2 publications

Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

Assessing muscle fatigue in multiple sclerosis using the sample entropy of electromyographic signals: A proof of concept

Estudio exploratorio para la validación de la Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) en la población con Esclerosis Múltiple Remitente Recurrente del Hospital San Juan de Dios en Santiago de Chile

Contact Info

Product

Resources

About